TGFB1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Taken together, these data suggested that Nrf2 was activated by UA treatment in TGF-β1-induced CFs and knocking down of Nrf2 could rescue the inhibition of UA on CMT process.